# Pfizer Inc. (PFE) — Q4-2025 Earnings Results

**Report date:** 2026-02-03 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/PFE/earnings/Q4-2025

## Post-Earnings Brief

### Headline

Pfizer Beats on EPS, Stock Down 3.34%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.66 | N/A | +16.81% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Management expressed a cautious optimism about future prospects. They emphasized the importance of innovation and adapting to market changes.

**Key quotes:**

> Management highlighted ongoing efforts to enhance product pipeline.

> They acknowledged challenges in the current market environment.

> Focus remains on long-term growth despite short-term pressures.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Pfizer's earnings report showed a positive surprise in EPS, indicating better-than-expected profitability. However, the stock fell by 3.34% likely due to the lack of revenue details and guidance, which left investors uncertain about future performance. The cautious tone from management may also have contributed to the stock's decline.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/PFE/earnings/Q4-2025_